关注
Ali Aflatounian
Ali Aflatounian
School of Women's and Children's Health, UNSW
在 unsw.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Androgens and ovarian function: translation from basic discovery research to clinical impact
K Walters, VR Paris, A Aflatounian, DJ Handelsman
Journal of Endocrinology 1 (aop), 2019
842019
Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model
A Aflatounian, MC Edwards, VR Paris, MJ Bertoldo, R Desai, RB Gilchrist, ...
Journal of Endocrinology 245 (3), 381-395, 2020
752020
Androgen action in adipose tissue and the brain are key mediators in the development of PCOS traits in a mouse model
MJ Cox, MC Edwards, V Rodriguez Paris, A Aflatounian, WL Ledger, ...
Endocrinology 161 (7), bqaa061, 2020
612020
Perinatal outcome in fresh versus frozen embryo transfer in ART cycles
A Aflatoonian, MAK Maybodi, N Aflatoonian, N Tabibnejad, ...
International Journal of Reproductive BioMedicine 14 (3), 167, 2016
482016
Maternal metabolic factors and the association with gestational diabetes: a systematic review and meta‐analysis
N Habibi, A Mousa, CT Tay, MB Khomami, RK Patten, PH Andraweera, ...
Diabetes/Metabolism Research and Reviews 38 (5), e3532, 2022
342022
The interplay between PCOS pathology and diet on gut microbiota in a mouse model
V Rodriguez Paris, XYD Wong, SM Solon-Biet, MC Edwards, ...
Gut Microbes 14 (1), 2085961, 2022
332022
Neurokinin 3 receptor antagonism ameliorates key metabolic features in a hyperandrogenic PCOS mouse model
IE Sucquart, R Nagarkar, MC Edwards, V Rodriguez Paris, A Aflatounian, ...
Endocrinology 162 (5), bqab020, 2021
292021
Pathogenesis of reproductive and metabolic PCOS traits in a mouse model
V Rodriguez Paris, MC Edwards, A Aflatounian, MJ Bertoldo, WL Ledger, ...
Journal of the Endocrine Society 5 (6), bvab060, 2021
202021
Declining muscle NAD+ in a hyperandrogenism PCOS mouse model: possible role in metabolic dysregulation
A Aflatounian, VR Paris, D Richani, MC Edwards, BJ Cochran, WL Ledger, ...
Molecular Metabolism 65, 101583, 2022
162022
Does adding adverse pregnancy outcomes improve the Framingham Cardiovascular Risk Score in women? Data from the Tehran Lipid and Glucose Study
M Saei Ghare Naz, A Sheidaei, A Aflatounian, F Azizi, ...
Journal of the American Heart Association 11 (2), e022349, 2022
122022
Chronic niacin administration ameliorates ovulation, histological changes in the ovary and adiponectin concentrations in a rat model of polycystic ovary syndrome
N Asadi, M Izadi, A Aflatounian, M Esmaeili-Dehaj, ME Rezvani, Z Hafizi
Reproduction, Fertility and Development 33 (7), 447-454, 2021
62021
Adolescents’ polycystic ovary syndrome health-related quality of life questionnaire (APQ-20): development and psychometric properties
M Saei Ghare Naz, G Ozgoli, F Ahmadi, H Alavi Majd, A Aflatounian, ...
European Journal of Pediatrics 182 (5), 2393-2407, 2023
32023
Pharmacological Antagonism of the Kisspeptin-Neurokinin System Improved Adverse Metabolic Traits in a PCOS Mouse Model
IE SUCQUART, R NAGARKAR, MC EDWARDS, VR PARIS, ...
Fertility & Reproduction 4 (03n04), 160-160, 2022
2022
Mitochondrial Uncoupler BAM15 Ameliorates Associated Metabolic PCOS Traits in a Hyperandrogenic PCOS Mouse Model
V RODRIGUEZ PARIS, SJ ALEXOPOULOS, Y HU, DP SHAH, ...
Fertility & Reproduction 4 (03n04), 208-208, 2022
2022
Polycystic Ovary Syndrome: Mechanisms of Development and Novel Treatments
A Aflatounian
UNSW Sydney, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–15